Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Lacosamide Genepharm 50mg


Contraindicated
Embryotoxic in animals

Contraindicated
As a precautionary measure
Lacosamide Genepharm 50mg :
Type Medicine Authorised
Originator Vimpat Tablets 50mg
Agent Nobel Pharm Plus
Distributor Dima HealthCare
Laboratory Genepharm
Responsible Party Genepharm SA
Origin Greece
Manufacturer Genepharm SA
Manufacturing Type G
Origin Greece
ATC N03AX18

Your comment will appear shortly after approval

Lacosamide Genepharm 50mg :

Revision Date : 06/02/2015


Effect Frequency
Aggression Uncommon
Agitation Uncommon
Agranulocytosis Not known
ALT increased Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Asthenia Common
Atrial fibrillation Uncommon
Atrial flutter Uncommon
Atrioventricular block (AVB) Uncommon
Balance disorder Common
Bradycardia Uncommon
Cognitive disorder Common
Confusional state Common
Constipation Common
Contusion Common
Coordination abnormal Common
Depression Common
Diarrhoea (Diarrhea) Common
Diplopia Very Common
Disturbance in attention Common
Dizziness Very Common
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Drug hypersensitivity Uncommon
Dry mouth (Xerostomia) Common
Dysarthria Common
Dyspepsia Common
ECG PR prolongation Not known
Euphoric mood Uncommon
Fall Common
Fatigue Common
Feeling drunk Common
Flatulence Common
Gait disturbance Common
Hallucination Uncommon
Headache Very Common
Hypoesthesia Common
Insomnia Common
Irritability Common
Laceration Common
Liver function test abnormal Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Memory impairment Common
Muscle spasms Common
Nausea Very Common
Nystagmus Common
Paraesthesia (paresthesia) Common
Pruritus Common
Psychotic disorders Uncommon
Pyrexia Not known
Skin rash Common
Somnolence Common
Stevens-Johnson syndrome Not known
Suicidal ideation Uncommon
Suicide attempt Uncommon
Syncope Not known
Tinnitus Common
Tremor Common
Urticaria Uncommon
Vertigo Common
Vision blurred Common
Vomiting Common

Different Units By MoH Code

Lacosamide Genepharm 50mg  MoH 10847 :
Form Tablet, Film-Coated
Package Size Box of 14
Strength 50mg
Public Price 614136.02 L.L.
Stratum A1
NSSF ✘
Quarantine ✘
Reg. Number 156019/1
Submission date 10/10/2019
Registration Year 06/06/2022
Pending Year 17/09/2020


Price Comparison

● Country: Lebanon
● Form: Tablet, Film-Coated
● Package Size: Box of 14
● Public Price: 614136.02 LBP ( 614,136.02 LBP )
● Pack size unit used: 14
● Cost/Unit: 43866,86 LBP ( 43,866.00 LBP )
● Pricing Date: 13/06/2024

● Country: Greece
● Package Size: 14
● Public Price: 7.27 EUR ( 704,288.52 LBP )
● Pack size unit used: 14
● Cost/Unit: 0,5193 EUR ( 0.00 LBP )
● Exfactory Price: 5.03 EUR
● Pharmacy Price: 5.28 EUR ( 511505.28 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info